Les Laboratoires Servier : Company Profile and SWOT Analysis

  • July 2012
  • -
  • World Market Intelligence Ltd
  • -
  • 22 pages

Synopsis

World Market Intelligence's 'Les Laboratoires Servier : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key competitors, key facts, key employees, location and subsidiaries as well as information on products and services.

Summary

This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business.

WMI's 'Les Laboratoires Servier : Company Profile and SWOT Analysis' report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.

WMI strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope

• Examines and identifies key information and issues about 'Les Laboratoires Servier' for business intelligence requirements
• Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported
• The profile also contains information on business operations, company history, major products and services, key employees


Reasons To Buy

• Quickly enhance your understanding of the company
• Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry
• Recognize potential partnerships and suppliers


Key Highlights

Les Laboratoires Servier (Servier) is a pharmaceutical company based in France. The company researches, develops, manufactures and markets drugs for the treatment of cardiovascular, asthenia, oncologic, endocrine, diabetes, and venous diseases. Furthermore, the company also produces drugs for the ENT, neurosciences, and asthenia diseases. Key products of the company include coversyl, coveram, hyperium, preterax, procoralan, valdoxan, duxil, diamicron mr, muphoran, arcalion, locabiotal, protelos, and daflon 500. It has ICTRs (International Centers for Therapeutic Research) located in 19 countries across Asia-Pacific, Europe, South America and Canada. Also, the company has presence in 140 countries across the world. Servier is headquartered in Neuilly Sur Seine, France.

Table Of Contents

Table of Contents

1 Business Analysis
1.1 Company Overview
1.2 Business Description
1.3 Major Products and Services
2 Mergers and Acquisitions and Partnerships
2.1 MandA and Partnerships Strategy
3 Recent Developments
4 SWOT Analysis
4.1 SWOT Analysis - Overview
4.2 Strengths
4.3 Weaknesses
4.4 Opportunities
4.5 Threats
5 Company Statement
6 History
7 Key Employees
8 Key Employee Biographies
9 Appendix
9.1 Methodology
9.2 Disclaimer


List of Tables

Table 1: Major Products and Services
Table 2: History
Table 3: Key Employees
Table 4: Key Employee Biographies

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

World Therapy: Postherpetic Neuralgia – Pipeline Review, H1 2012

World Therapy: Postherpetic Neuralgia – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • March 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Postherpetic Neuralgia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

World Therapy: Wounds – Pipeline Review, H1 2012

World Therapy: Wounds – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • April 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Wounds, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in ...

World Pathology: Diabetic Nephropathy – Pipeline Review, H1 2012

World Pathology: Diabetic Nephropathy – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • March 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Diabetic Nephropathy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.